Real-World Experience with (177)Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval. Moradi Tuchayi A, Yadav S, Jiang F, Kim ST, et al. J Nucl Med 2024;65:735-739.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moradi Tuchayi A, Yadav S, Jiang F, Kim ST, et al. Real-World Experience with (177)Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval. J Nucl Med 2024;65:735-739.
PMID: 38485274